Ayça Dönmez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ayça Dönmez has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Barkın Kültürsay
Department of Cardiology, Tunceli State Hospital, Tunceli, Turkey
1 shared publication - Barış Güven
Department of Cardiology, Liv Hospital Ulus, Istanbul 34340, Turkey
1 shared publication Cihan Ozturk
Trakya Univ, Fac Med, Dept Cardiol, Edirne, Turkey
1 shared publicationEdirne- Turkey
1 shared publication- Kenan Yalta
Cardiology Department Trakya University Edirne Turkey
1 shared publication - Melike Kaya
Department of Cardiology, Istanbul University–Cerrahpaşa, Institute of Cardiology , Haseki, Fatih, Istanbul 34098
1 shared publication
Latest Publications
- 24 March 2025
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 19 (8) , 287-294
A novel indicator of all-cause mortality in acute coronary syndrome: the CALLY index
This study aimed to identify the prognostic significance of the C-reactive protein-albumin-lymphocyte (CALLY) index for predicting all-cause mortality in acute coronary syndrome (ACS) patients who have undergone primary percutaneous coronary intervention (pPCI) for revascularization. 505 patients who presented with ACS and underwent pPCI were retrospectively included in this single center study. CALLY index and other five prognostic scores were calculated. The median follow-up was 40 months. All-cause mortality was defined as the primary endpoint. The median age of the patients was 59 years, 23.4% were female. The CALLY index was categorized into low (p = 0.038), concomitant atrial fibrillation (p = 0.023), previous CABG (p = 0.001), ACE-I/ARB/ARNI use (p = 0.015), diuretic use (p = 0.021), and a low-CALLY index (p < 0.001) were identified as independent predictors of all-cause mortality in multivariate cox regression analysis. When compared to other prognostic scores according to AUC in ROC analysis, the CALLY index demonstrated the best ability to predict all-cause mortality. Additionally, patients with a high-CALLY index exhibited significantly better survival outcomes compared to those with a low-CALLY index (log-rank:p < 0.001). CALLY index can be utilized as a novel prognostic score for predicting all-cause mortality in ACS patients who have undergone pPCI.
- 24 March 2025
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 19 (8) , 287-294
A novel indicator of all-cause mortality in acute coronary syndrome: the CALLY index
This study aimed to identify the prognostic significance of the C-reactive protein-albumin-lymphocyte (CALLY) index for predicting all-cause mortality in acute coronary syndrome (ACS) patients who have undergone primary percutaneous coronary intervention (pPCI) for revascularization. 505 patients who presented with ACS and underwent pPCI were retrospectively included in this single center study. CALLY index and other five prognostic scores were calculated. The median follow-up was 40 months. All-cause mortality was defined as the primary endpoint. The median age of the patients was 59 years, 23.4% were female. The CALLY index was categorized into low (p = 0.038), concomitant atrial fibrillation (p = 0.023), previous CABG (p = 0.001), ACE-I/ARB/ARNI use (p = 0.015), diuretic use (p = 0.021), and a low-CALLY index (p < 0.001) were identified as independent predictors of all-cause mortality in multivariate cox regression analysis. When compared to other prognostic scores according to AUC in ROC analysis, the CALLY index demonstrated the best ability to predict all-cause mortality. Additionally, patients with a high-CALLY index exhibited significantly better survival outcomes compared to those with a low-CALLY index (log-rank:p < 0.001). CALLY index can be utilized as a novel prognostic score for predicting all-cause mortality in ACS patients who have undergone pPCI.
- Open Access
- 3 August 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (8) , 598-599
Intracoronary fibrinolysis: An effective yet underutilized therapeutic strategy in clinical practice
- 3 August 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (8) , 598-599
Open AccessIntracoronary fibrinolysis: An effective yet underutilized therapeutic strategy in clinical practice